Position in JNJ
as of Mar 31, 2026
· filed May 19, 2026
Position Value
$2,361,045
+$353,837 QoQ
Shares Held
9,659
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Silicon Valley Capital Partners holds $14,966,250 across 12 Drug Manufacturers - General names. JNJ ranks #2 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,009 | $11,965,287 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
9,659 | $2,361,045 | |
| 3 | PFE |
Pfizer Inc
|
7,397 | $207,707 | |
| 4 | AMGN |
Amgen Inc
|
487 | $171,350 | |
| 5 | ABBV |
AbbVie Inc.
|
580 | $126,144 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,154 | $69,990 | |
| 7 | MRK |
Merck & Co., Inc.
|
380 | $45,710 | |
| 8 | NVO |
Novo Nordisk A S
|
276 | $10,143 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,361,045 | 9,659 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $2,007,208 | 9,699 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,797,461 | 9,694 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,600,514 | 10,478 | Shares | Sole | 2025-09-11 | |
| 2025-03-31 | $1,769,844 | 10,672 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $519,908 | 3,595 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $580,336 | 3,581 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $521,498 | 3,568 | Shares | Sole | 2024-10-30 | |
| 2024-03-31 | $577,077 | 3,648 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $585,423 | 3,735 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $579,701 | 3,722 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $1,833,630 | 11,078 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,686,555 | 10,881 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,920,008 | 10,869 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,826,854 | 11,183 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,985,626 | 11,186 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $1,962,645 | 11,074 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,902,640 | 11,122 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,794,265 | 11,110 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,776,720 | 10,785 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,466,823 | 8,925 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $286,116 | 1,818 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $271,259 | 1,822 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||